Norway Personalized Medicine Market Size & Outlook
- Root
- Biotechnology
- Personalized Medicine Market Outlook
- Biotechnology
Global Market
Related Markets
Ask Prism AI about the personalized medicine market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Norway personalized medicine market highlights
- The Norway personalized medicine market generated a revenue of USD 6,234.5 million in 2024 and is expected to reach USD 12,149.5 million by 2033.
- The Norway market is expected to grow at a CAGR of 7.8% from 2025 to 2033.
- In terms of segment, personalized nutrition & wellness was the largest revenue generating product in 2024.
- PM Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.
Personalized medicine market data book summary
| Market revenue in 2024 | USD 6,234.5 million |
| Market revenue in 2033 | USD 12,149.5 million |
| Growth rate | 7.8% (CAGR from 2025 to 2033) |
| Largest segment | Personalized nutrition & wellness |
| Fastest growing segment | PM Therapeutics |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Illumina Inc, Asure Software Inc, Abbott Laboratories, Danaos Corp, Exact Sciences Corp, Danaher Corp, Amgen Inc, Qiagen NV, Exagen Inc Ordinary Shares, Quest Diagnostics Inc, Biogen Inc, Genelux Corp, International Business Machines Corp, Genentech, 23andMe Holding Co Class A |
Other key industry trends
- In terms of revenue, Norway accounted for 1.1% of the global personalized medicine market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany personalized medicine market is projected to lead the regional market in terms of revenue in 2033.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 72,295.2 million by 2033.
In December 2021, Illumina, Inc. announced that it would be supporting Norway’s precision medicine study to evaluate blood-based Comprehensive Genomic Profiling (CGP) efficiency in the selection of cancer therapy. The study would also evaluate the cost-effectiveness of blood-based CGP implementation in the healthcare system .
Norway has established a network of drug information centers, Regionale legemiddelinformasjonssentre (RELIS). This service promotes access to personalized medicine in the country.
No credit card required*
Publish Date: Jul 09, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Personalized Medicine Market Scope
Personalized Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Amgen Inc | View profile | 26,700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | www.amgen.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| International Business Machines Corp | View profile | 282,200 | One New Orchard Road, Armonk, NY, United States, 10504 | www.ibm.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Exact Sciences Corp | View profile | 6,600 | 5505 Endeavor Lane, Madison, WI, United States, 53719 | www.exactsciences.com |
| Asure Software Inc | View profile | 581 | 405 Colorado Street, Suite 1800, Austin, TX, United States, 78701 | www.asuresoftware.com |
Norway Personalized Medicine Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Personalized Medicine Market Outlook will help companies and investors design strategic landscapes.
Personalized Nutrition & Wellness was the largest segment with a revenue share of 33.56% in 2024.
Horizon Databook has segmented the Norway personalized medicine market based on pm diagnostics, pm therapeutics, personalized medical care, personalized nutrition & wellness covering the revenue growth of each sub-segment from 2021 to 2033.
In December 2021, Illumina, Inc. announced that it would be supporting Norway’s precision medicine study to evaluate blood-based Comprehensive Genomic Profiling (CGP) efficiency in the selection of cancer therapy. The study would also evaluate the cost-effectiveness of blood-based CGP implementation in the healthcare system .
Norway has established a network of drug information centers, Regionale legemiddelinformasjonssentre (RELIS). This service promotes access to personalized medicine in the country.
- Norway Personalized Medicine Market Product Outlook (Revenue, USD Million , 2021-2033)
- PM Diagnostics
- PM Therapeutics
- Personalized Medical Care
- Personalized Nutrition & Wellness
Reasons to subscribe to Personalized Medicine Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Personalized Medicine Market Outlook databook
- Our clientele includes a mix of Personalized Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway Personalized Medicine Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Norway Personalized Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Norway Personalized Medicine Market, 2021-2033 (US$M)
Norway Product - Personalized Medicine Market Statistics, 2024 - 2033 (US$M)
